Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer
Qiang Li,Sheng Jiang,Tienan Feng,Tengteng Zhu,Biyun Qian
DOI: https://doi.org/10.2147/ott.s301127
IF: 4
2021-05-13
OncoTargets and Therapy
Abstract:Qiang Li, 1, 2, * Sheng Jiang, 3, * Tienan Feng, 2 Tengteng Zhu, 2 Biyun Qian 2 1 Public Health College, Shanghai Jiao Tong University of Medicine, Shanghai, 200025, People's Republic of China; 2 Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China; 3 The Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, 610051, People's Republic of China *These authors contributed equally to this work Correspondence: Tengteng Zhu; Biyun Qian Hongqiao International Institute of Medicine, Shanghai Tongren Hospital/Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, 227 Chongqing South Road, Shanghai, 200025, China Email ; Background: The detection rate of thyroid cancer (TC) has been continuously improved due to the development of detection technology. Epithelial–mesenchymal transition (EMT) is thought to be closely related to the malignant progression of tumors. However, the relationship between EMT-related genes (ERGs) characteristics and the diagnosis and prognosis of TC patients has not been studied. Methods: Four datasets from Gene Expression Omnibus (GEO) were used to perform transcriptomic profile analysis. The overlapping differentially expressed ERGs (DEERGs) were analyzed using the R package "limma". Then, the hub genes, which had a higher degree, were identified by the protein–protein interaction (PPI) network. Gene expression analysis between the TC and normal data, the disease-free survival (DFS) analysis of TC patients from The Cancer Genome Atlas Thyroid Cancer (TCGA-THCA) cohort, function analysis, and immunohistochemistry (IHC) were performed to verify the importance of the hub genes. Finally, a prognostic risk scoring was constructed to predict DFS in patients with the selected genes. Results: A total of 43 DEERGs were identified and 10 DEERGs were considered hub ERGs, which had a high degree of connectivity in the PPI network. Then, the differential expressions of FN1, ITGA2 , and KIT between TC and normal tissues were verified in the TCGA-THCA cohort and their protein expressions were also verified by IHC. DFS analysis indicated upregulations of FN1 expression ( P < 0.01) and ITGA2 expression ( P < 0.01) and downregulation of KIT expression ( P =0.01) increased risks of decreased DFS for TCGA-THCA patients. Besides, by building a prognostic risk scoring model, we found that the DFS of TCGA-THCA patients was significantly worse in high-risk groups. Conclusion: In summary, these hub ERGs were potential biomarkers for diagnosis and prognosis of TC, which can provide a basis for further exploring the efficacy of EMT in patients with TC. Keywords: thyroid cancer, EMT, signature, bioinformatic analysis, immunohistochemistry Thyroid cancer (TC) is the most common endocrine malignancy. In the past 40 years, the incidence of TC has risen steadily in many countries around the world. 1 With the improvement of detection technology, the incidence of recent TC in China in 2014 was 12.40/100,000, making it one of the fastest-growing malignant tumors. 2 Although the incidence of TC is increasing year by year, the mortality rate of TC is stable or decreased slightly due to early diagnosis. 3 , 4 Ultrasonography is the main method for stratifying the risk of early cancerous thyroid nodules. Patients with suspected TC could take a fine-needle aspiration biopsy (FNAB) or surgical resection, and followed by a pathological examination to assess the nature of cancer. 5 However, in some cases, due to the overlapping of cytological features of malignant and benign thyroid nodules, approximately 15%-30% of biopsies are uncertain. 6 And the uncertain diagnosis may bring inappropriate treatment leading to poor quality of life, such as the surgical removal of the thyroid will seriously affect the quality of life of patients. Ultrasound and FNAB can only be diagnosed and cannot respond to the question of whether to perform surgery. Therefore, supplementing and improving traditional diagnostic methods of TC patients is still an urgent problem to be addressed. Epithelial–mesenchymal transition (EMT) is one of the markers of carcinogenesis, which includes the re-differentiation of epithelial cells into mesenchymal cells, making the cell phenotype mali -Abstract Truncated-
oncology,biotechnology & applied microbiology